36 related articles for article (PubMed ID: 8066205)
1. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
Pritchard-Jones K; Bergeron C; de Camargo B; van den Heuvel-Eibrink MM; Acha T; Godzinski J; Oldenburger F; Boccon-Gibod L; Leuschner I; Vujanic G; Sandstedt B; de Kraker J; van Tinteren H; Graf N;
Lancet; 2015 Sep; 386(9999):1156-64. PubMed ID: 26164096
[TBL] [Abstract][Full Text] [Related]
2. Kidney Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.
Poppe MM; Tai A; Li XA; Miften M; Olch A; Marks LB; Qureshi BM; Spunt SL; Shnorhavorian M; Nelson G; Ronckers C; Kalapurakal J; Marples B; Constine LS; Liu AK
Int J Radiat Oncol Biol Phys; 2024 Jun; 119(2):560-574. PubMed ID: 37452796
[TBL] [Abstract][Full Text] [Related]
3. Liver Late Effects in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.
Hall MD; Howell RM; Jackson A; Owens CA; Hernandez S; Castellino SM; Ronckers CM; Constine LS; Bradley JA
Int J Radiat Oncol Biol Phys; 2024 Jun; 119(2):575-587. PubMed ID: 37480885
[TBL] [Abstract][Full Text] [Related]
4. Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30-year SIOP-RTSG experience.
Vujanić GM; Graf N; D'Hooghe E; Pritchard-Jones K; Bergeron C; Tinteren HV; Furtwängler R;
Pediatr Blood Cancer; 2024 Mar; 71(3):e30852. PubMed ID: 38185745
[TBL] [Abstract][Full Text] [Related]
5. Nephroblastoma--a 25-year review of a South African unit.
Visser YT; Uys R; van Zyl A; Stefan DC
J Med Life; 2014 Sep; 7(3):445-9. PubMed ID: 25408773
[TBL] [Abstract][Full Text] [Related]
6. Exploiting clinical trial data drastically narrows the window of possible solutions to the problem of clinical adaptation of a multiscale cancer model.
Stamatakos GS; Georgiadi EC; Graf N; Kolokotroni EA; Dionysiou DD
PLoS One; 2011 Mar; 6(3):e17594. PubMed ID: 21407827
[TBL] [Abstract][Full Text] [Related]
7. Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of Chemotherapy.
Oosterom N; Gooskens SLM; Renfro LA; Perlman EJ; van den Heuvel-Eibrink MM; Hamilton TE; Green DM; Grundy PE; Daw NC; Geller JI; Dome JS; Fernandez CV; Mullen EA
J Clin Oncol; 2023 Sep; 41(26):4247-4256. PubMed ID: 37343199
[TBL] [Abstract][Full Text] [Related]
8. Estimated clinical benefit of combining highly conformal target volumes with Volumetric-Modulated Arc Therapy (VMAT) versus conventional flank irradiation in pediatric renal tumors.
Mul J; Seravalli E; Bosman ME; van de Ven CP; Littooij AS; van Grotel M; van den Heuvel-Eibrink MM; Janssens GO
Clin Transl Radiat Oncol; 2021 Jul; 29():20-26. PubMed ID: 34027140
[TBL] [Abstract][Full Text] [Related]
9. Hepatic sinusoidal obstruction syndrome during chemotherapy for childhood medulloblastoma: report of a case and review of the literature.
Kotecha RS; Buckland A; Phillips MB; Cole CH; Gottardo NG
J Pediatr Hematol Oncol; 2014 Jan; 36(1):76-80. PubMed ID: 24276042
[TBL] [Abstract][Full Text] [Related]
10. Hepato-biliary late effects in survivors of childhood and adolescent cancer: a report from the Children's Oncology Group.
Castellino S; Muir A; Shah A; Shope S; McMullen K; Ruble K; Barber A; Davidoff A; Hudson MM
Pediatr Blood Cancer; 2010 May; 54(5):663-9. PubMed ID: 19890896
[TBL] [Abstract][Full Text] [Related]
11. Study protocol of the German "Registry for the detection of late sequelae after radiotherapy in childhood and adolescence" (RiSK).
Bolling T; Schuck A; Pape H; Rube C; Pollinger B; Timmermann B; Kortmann RD; Dieckmann K; Willich N
Radiat Oncol; 2008 Apr; 3():10. PubMed ID: 18426567
[TBL] [Abstract][Full Text] [Related]
12. Hepatotoxicity in patients treated according to the nephroblastoma trial and study SIOP-9/GPOH.
Ludwig R; Weirich A; Abel U; Hofmann W; Graf N; Tournade MF
Med Pediatr Oncol; 1999 Nov; 33(5):462-9. PubMed ID: 10531570
[TBL] [Abstract][Full Text] [Related]
13. Update on relapses in unilateral nephroblastoma registered in 3 consecutive SIOP/GPOH studies - a report from the GPOH-nephroblastoma study group.
Furtwängler R; Nourkami N; Alkassar M; von Schweinitz D; Schenk JP; Rübe C; Siemer S; Leuschner I; Graf N
Klin Padiatr; 2011 May; 223(3):113-9. PubMed ID: 21509706
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy in Wilms' tumour.
Thomas PR
Ann Acad Med Singap; 1996 May; 25(3):425-8. PubMed ID: 8876911
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy in the SIOP (International Society of Pediatric Oncology) nephroblastoma studies: a review.
Jereb B; Burgers JM; Tournade MF; Lemerle J; Bey P; DeLemarre J; Habrand JL; Voûte PA
Med Pediatr Oncol; 1994; 22(4):221-7. PubMed ID: 8107651
[TBL] [Abstract][Full Text] [Related]
16. Hepatotoxicity in irradiated nephroblastoma patients during postoperative treatment according to SIOP9/GPOH.
Flentje M; Weirich A; Pötter R; Ludwig R
Radiother Oncol; 1994 Jun; 31(3):222-8. PubMed ID: 8066205
[TBL] [Abstract][Full Text] [Related]
17. Abdominal irradiation in unilateral nephroblastoma and its impact on local control and survival.
Flentje M; Weirich A; Graf N; Pötter R; Zimmerman H; Ludwig R
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):163-9. PubMed ID: 9422573
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
